Literature DB >> 33336406

The role of Interleukin-32 in autoimmunity.

Rafael de Albuquerque1, Elina Komsi1, Inna Starskaia1, Ubaid Ullah1, Riitta Lahesmaa1.   

Abstract

Interleukin-32 (IL-32) is a pro-inflammatory cytokine that induces other cytokines involved in inflammation, including tumour necrosis factor (TNF)-α, IL-6 and IL-1β. Recent evidence suggests that IL-32 has a crucial role in host defence against pathogens, as well as in the pathogenesis of chronic inflammation. Abnormal IL-32 expression has been linked to several autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel diseases, and a recent study suggested the importance of IL-32 in the pathogenesis of type 1 diabetes. However, despite accumulating evidence, many molecular characteristics of this cytokine, including the secretory route and the receptor for IL-32, remain largely unknown. In addition, the IL-32 gene is found in higher mammals but not in rodents. In this review, we outline the current knowledge of IL-32 biological functions, properties, and its role in autoimmune diseases. We particularly highlight the role of IL-32 in rheumatoid arthritis and type 1 diabetes.
© 2020 The Authors. Scandinavian Journal of Immunology published by John Wiley & Sons Ltd on behalf of The Scandinavian Foundation for Immunology.

Entities:  

Keywords:  Interleukin-32; rheumatoid arthritis; type 1 diabetes

Mesh:

Substances:

Year:  2021        PMID: 33336406     DOI: 10.1111/sji.13012

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology.

Authors:  Dandan Zhao; Xiaoxiao Zhang; Yuhui Tang; Peilin Guo; Rong Ai; Mengmeng Hou; Yiqi Wang; Xiwei Yuan; Luyao Cui; Yuguo Zhang; Suxian Zhao; Wencong Li; Yang Wang; Xiaoye Sun; Lingdi Liu; Shiming Dong; Lu Li; Wen Zhao; Yuemin Nan
Journal:  J Hepatocell Carcinoma       Date:  2022-05-09

2.  Early DNA methylation changes in children developing beta cell autoimmunity at a young age.

Authors:  Inna Starskaia; Essi Laajala; Toni Grönroos; Taina Härkönen; Sini Junttila; Roosa Kattelus; Henna Kallionpää; Asta Laiho; Veronika Suni; Vallo Tillmann; Riikka Lund; Laura L Elo; Harri Lähdesmäki; Mikael Knip; Ubaid Ullah Kalim; Riitta Lahesmaa
Journal:  Diabetologia       Date:  2022-02-10       Impact factor: 10.122

3.  Proinflammatory cytokines induce rapid, NO-independent apoptosis, expression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells.

Authors:  Rabea Dettmer; Isabell Niwolik; Karsten Cirksena; Toshiaki Yoshimoto; Yadi Tang; Ilir Mehmeti; Ewa Gurgul-Convey; Ortwin Naujok
Journal:  Diabetologia       Date:  2022-02-05       Impact factor: 10.122

4.  Interleukin 32 participates in cardiomyocyte-induced oxidative stress, inflammation and apoptosis during hypoxia/reoxygenation via the NOD2/NOX2/MAPK signaling pathway.

Authors:  Yuanyuan Li; Zhongyan Wang
Journal:  Exp Ther Med       Date:  2022-07-12       Impact factor: 2.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.